Perhaps the main goal that encourages people to start a weight control program is only the loss of body fat and improve personal appearance. However, obesity should be considered as a disease that increases the risk of other pathologies, increases health care costs and reduces the years of life of people. (one)
In this sense, the modest decrease in weight, but maintained in the long term, is accompanied by several health benefits. (2) For example, it reduces the risk of cancer and joint disease, increases the fertility rate in women, improves self-esteem and quality of life, among other benefits (Table 1).
Healthy eating and regular exercise are considered basic principles of obesity treatment. Another therapeutic option includes pharmacological therapy, which in well-selected patients and with adequate follow-up, favors the achievement of therapeutic objectives. (3)
Table 1. Benefits of losing 10% of initial weight (Redotex before and after)
↓ 10 mmHg blood pressure (in patients with hypertension)
↓ up to 50% blood glucose (in patients with diabetes)
↓ “bad” cholesterol (LDL-C) by 15%
↓ triglycerides (fats in blood) in 30%
↓ obesity-related deaths in more than 40%
↑ insulin sensitivity 30%
↑ “good” cholesterol (C-HDL)
Source: reference. (4)
Redotex before and after: pills or capsules to lose weight?
In reality, more than capsules or pills to lose weight, Redotex is a drug available and authorized since 1956 as an adjunct in the treatment of obesity in adults in Mexico. (5)
This medicine contains five drugs or active substances (D-norpseudoephedrine, liothyronine, diazepam, aloin and atropine) that have specific actions and are focused on reducing hunger, increasing fat degradation and reducing anxiety. (5)
Redotex before and after How long can I take Redotex?
According to studies conducted in Mexican adults, Redotex can be consumed effectively and safely for six months of continuous treatment. (5.6)
However, the treating doctor establishes, according to the characteristics of the patient and the objectives that he pursues, the duration of the treatment.
How Redotex Works
Redotex is composed of: a) D-norpseudoephedrine hydrochloride, a substance that acts in the brain and reduces hunger; b) liothyronine, a synthetic form of the thyroid hormone that increases fat breakdown (lipolysis); c) diazepam, a drug that reduces anxiety; d) aloin, derived from aloe vera that counteracts constipation; e) atropine, reduces the secretion of saliva and gastric juices, therefore also decreases hunger. (5)
In summary, Redotex by reducing hunger favors the follow-up of the low-energy eating plan, promotes the breakdown of fat into its simplest components so that they can be used as an energy source with the help of exercise and facilitates adequate intestinal transit ( without causing diarrhea). (5)
Redotex before and after How should Redotex be taken?
In clinical studies, the dose considered to be safe and effective for the treatment of obesity consists of one capsule per day. (5,6) Unfortunately, in order to increase the rate of weight loss, some people may increase the dose of the medication, which increases the probability of presenting adverse events, a situation that creates an environment of uncertainty and insecurity compared to this class. of medications. To reduce this risk, you must follow the instructions outlined by your doctor. You cannot buy Redotex without a prescription!
What adverse events can occur when taking Redotex?
All medications, even when consumed in the indicated dose, can cause secondary events. In the case of Redotex, it has been documented in studies that most of them are mild (94.5%) and consist mainly of dry mouth, excessive thirst, constipation, headache, irritability, nervousness, anxiety, nausea, dizziness and disorders of the dream. (5-7)
It should also be borne in mind that some patients may consume alcoholic or caffeinated beverages while consuming this class of medications, which alone can cause an increase in heart rate and blood pressure or insomnia. Therefore, anti-obesity drugs that act on the brain should not be combined with such drinks. (8-10)
Redotex before and after does it cause a rebound?
First, the term “rebound” refers to weight gain that occurs after an intervention focused on weight reduction has been “completed” and is generally blamed for the medication. However, as in other chronic interventions such as diabetes, the patient consumes his medication and improves glucose control, but when he suspends not only the drug but also diet and exercise recommendations, the normal response to discontinuation of treatment occurs, that is, increased glucose in the blood. Furthermore, in the field of obesity, when the patient reaches a plateau stage where, despite continuing with the therapeutic indications, no more weight is lost, this fact is interpreted, erroneously, as the development of tolerance to medicine,(eleven)
Therefore, Redotex, and in general anti-obesity drugs do not produce “rebound”, the weight gain that usually occurs after an intervention that involves lifestyle modification is the normal result of abandonment of treatment. pharmacological agent of weight gain when it has been suspended? If he was responsible, the weight gain should occur while consuming the drug, right? but the opposite occurs, which demonstrates the efficacy and logic of the pharmacological treatment. (11) Figure 1 presents a series of behaviors that can help maintain weight loss in the long term.
Redotex, before and after in summary:
1. Redotex, more than capsules or pills to lose weight, is a drug authorized for the treatment of obesity in association with intervention in lifestyle (diet and exercise).
2. Redotex formulation reduces hunger and anxiety and promotes the degradation of stored fat (lipolysis).
3. Redotex has demonstrated its safety and efficacy in 6-month-long treatments.
4. Like all Redotex medications, it is not exempt from adverse events, however, most of them are mild (94.5%) and consist mainly of dry mouth, excessive thirst, constipation, headache, irritability, nervousness, anxiety, nausea, dizziness and sleep disorders.
5. Redotex does not have a “rebound” effect, the weight gain that can occur after a therapeutic intervention focused on weight loss is a normal response of the body to the suspension of all treatment (diet + exercise + drug therapy).
6. Pharmacological anti-obesity therapy is not a substitute for diet or physical activity. The drug will further reduce body weight.
References
- Rivera-Dommarco JA, Hernández-Ávila M, Aguilar-Salinas CA, et al. Obesity in mexico. Recommendations for a State policy. Mexico: National Autonomous University of Mexico; 2012.
- Haslam D, Sattar N, Lean M. ABC of obesity. Obesity time to wake up. BMJ. 2006; 333: 640-642.
- RD caves. Medical treatment of obesity. In: Méndez-Sánchez N, Uribe EW. Editors. Obesity. Clinical and therapeutic conceots. Mexico: McGraw-Hill; 2013. pp. 233-248.
- Haslam D, Sattar N, Lean M. ABC of obesity. Obesity time to wake up. BMJ. 2006; 333: 640-642.
- Del Valle-Laisequilla CF, Trejo-Jasso C, Huerta-Cruz JC, et al. Efficacy and safety of a fixed-dose combination of D-norpseudoephedrine, triiodothyronine, atropine, aloin, and diazepam in obese patients. Int J Clin Pharmacol Ther. 2018; 56 (11): 531-538.
- Morín ZR, Lonngi G, Alcaraz OR, Rosas HD. Comparison of two formulations of d-norpseudoephedrine and placebo in obese patients treated for six months. Med Int Mex. 2001; 17 (6): 260-71.
- Galicia-Quintanar C, del Valle-Laisequilla CF, Soto-Molina H. et al. Adverse Events Reactions Reported With the Use of a Fixed-Dose Combination of Nor-Pseudoephedrine, Triiodothyronine, Atropine, Aloin and Diazepam in Obese Mexican Patients. J Pharmacovigil. 2015; 3: 185.
- Watson EJ, Coates AM, Kohler M, Banks S. Caffeine consumption and sleep quality in Australian Adults. Nutrients. 2016; 8 (8): 479.
- Husain K, Ansari RA, Ferder L. Alcohol-induced hypertension: Mechanism and prevention. World J Cardiol. 2014; 6 (5): 245-252.
- Owens JA, Mindell J, Baylor A. Effect of energy drink and caffeinated beverage consumption on sleep, mood, and performance in children and adolescents. Nutr Rev. 2014; 72 Suppl 1: 65-71.
- Finer N. Present and future pharmacological approaches. Br Med Bull. 1997; 53 (2): 409-32.
- Stubbs J, Whybrow S, Teixeira P, et al. Problems in identifying predictors and correlates of weight loss and maintenance: implications for weight control therapies based on behavior change. Obes Rev. 2011; 12: 688-708.